Serotonin Syndrome Risk
Serotonin syndrome is a potentially fatal condition caused by excessive serotonergic activity, most often from drug combinations. Recognizing the precipitants is critical for prevention.
## Pathophysiology
Serotonin syndrome results from excessive stimulation of 5-HT1A and 5-HT2A receptors in the central and peripheral nervous systems. It is a predictable, dose-related toxicity rather than an idiosyncratic reaction. The Hunter Serotonin Toxicity Criteria provide the most accurate diagnostic framework, requiring the presence of a serotonergic agent plus specific clinical features.
## Clinical Triad
- **Neuromuscular excitation**: clonus (spontaneous, inducible, or ocular), hyperreflexia, rigidity, tremor
- **Autonomic dysfunction**: hyperthermia, tachycardia, diaphoresis, mydriasis, diarrhea
- **Altered mental status**: agitation, confusion, hypomania
Symptoms typically develop within 24 hours of the precipitating dose change, often within 6 hours. Mild cases cause tremor and anxiety; severe cases progress to hyperthermia above 41.1C, seizures, rhabdomyolysis, DIC, and death.
## High-Risk Drug Combinations
### MAOIs + Serotonergic Agents
The most dangerous combination. MAOIs (phenelzine, tranylcypromine, linezolid, methylene blue) prevent serotonin breakdown. Combined with any serotonin-releasing or reuptake-inhibiting drug, the result can be fatal:
- MAOI + SSRI/SNRI — the classic lethal combination
- MAOI + meperidine — releases serotonin; caused numerous fatalities
- MAOI + dextromethorphan — OTC cough suppressant with serotonin reuptake inhibition
A 14-day washout is required between discontinuing an MAOI and starting an SSRI (5 weeks for fluoxetine due to norfluoxetine's long half-life).
### Other Precipitant Combinations
| Drug A | Drug B | Mechanism |
|--------|--------|-----------|
| SSRI | Tramadol | Dual reuptake inhibition |
| SSRI | Triptans | 5-HT1 agonism (risk lower than previously thought) |
| SSRI | Lithium | Enhanced serotonin response |
| SSRI | Linezolid | Linezolid is a reversible MAOI |
| Venlafaxine | Mirtazapine | Dual serotonergic mechanisms |
## Commonly Overlooked Serotonergic Drugs
- **Linezolid** — antibiotic, reversible non-selective MAOI
- **Methylene blue** — surgical dye, potent MAO-A inhibitor
- **Fentanyl** — weak serotonin reuptake inhibitor at high doses
- **Ondansetron** — 5-HT3 antagonist; risk is very low but case reports exist
- **St. John's wort** — multiple serotonergic mechanisms
## Treatment
Treatment is primarily supportive: discontinue all serotonergic agents, provide IV fluids, benzodiazepines for agitation, and active cooling. Cyproheptadine (5-HT2A antagonist, 12 mg initially, then 2 mg every 2 hours) is the specific antidote, available only orally. Avoid paralytic agents that mask clonus assessment.
## Key Takeaways
- Serotonin syndrome is dose-related and predictable, not idiosyncratic
- MAOI combinations are the most dangerous; respect washout periods strictly
- Linezolid and methylene blue are often-forgotten MAOIs
- Symptoms develop within hours; clonus is the most reliable diagnostic sign
- Treatment: stop offending agents, benzodiazepines, cooling, cyproheptadine